
Rita J. Desai
Examiner (ID: 6660)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625 |
| Total Applications | 2152 |
| Issued Applications | 1294 |
| Pending Applications | 146 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11083745
[patent_doc_number] => 20160280707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'ALKOXY SUBSTITUTED IMIDAZOQUINOLINES'
[patent_app_type] => utility
[patent_app_number] => 15/181068
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94446
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/181068 | Alkoxy substituted imidazoquinolines | Jun 12, 2016 | Issued |
Array
(
[id] => 11083742
[patent_doc_number] => 20160280708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1'
[patent_app_type] => utility
[patent_app_number] => 15/178838
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10281
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15178838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/178838 | Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 | Jun 9, 2016 | Issued |
Array
(
[id] => 15070887
[patent_doc_number] => 10464919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
[patent_app_type] => utility
[patent_app_number] => 15/579692
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21391
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579692 | Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same | Jun 2, 2016 | Issued |
Array
(
[id] => 12728593
[patent_doc_number] => 20180134698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/578790
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578790
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578790 | Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of use | Jun 2, 2016 | Issued |
Array
(
[id] => 11568561
[patent_doc_number] => 20170107205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 15/170263
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49385
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15170263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/170263 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | May 31, 2016 | Abandoned |
Array
(
[id] => 11568561
[patent_doc_number] => 20170107205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 15/170263
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49385
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15170263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/170263 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | May 31, 2016 | Abandoned |
Array
(
[id] => 11074142
[patent_doc_number] => 20160271107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency'
[patent_app_type] => utility
[patent_app_number] => 15/168906
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16366
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/168906 | Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency | May 30, 2016 | Abandoned |
Array
(
[id] => 13325777
[patent_doc_number] => 20180214426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PYRAZOLO[4,3-C]QUINOLINE DERIVATIVES FOR INHIBITION OF BETA-GLUCURONIDASE
[patent_app_type] => utility
[patent_app_number] => 15/577201
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577201 | Pyrazolo[4,3-c]quinoline derivatives for inhibition of b-glucuronidase | May 25, 2016 | Issued |
Array
(
[id] => 11121974
[patent_doc_number] => 20160318948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'Compounds Inhibiting Eukaryotic Elongation Factor 2 Kinase Activity'
[patent_app_type] => utility
[patent_app_number] => 15/152941
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12442
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/152941 | Compounds inhibiting eukaryotic elongation factor 2 kinase activity | May 11, 2016 | Issued |
Array
(
[id] => 12790525
[patent_doc_number] => 20180155344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => TRICYCLIC PIPERIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/571700
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571700
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571700 | TRICYCLIC PIPERIDINE COMPOUNDS | May 2, 2016 | Abandoned |
Array
(
[id] => 12790501
[patent_doc_number] => 20180155336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => PROCESS FOR THE PREPARATION OF 2-{4-[2-({[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]METHYL}SULFANYL)-3,5-DICYAN0-6-(PYRROLIDIN-1-YL)PYRIDIN-4-YL]PHENOXY}ETHYL-L-ALANYL-L-ALANINATE MONOHYDROCHLORIDE
[patent_app_type] => utility
[patent_app_number] => 15/568575
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/568575 | PROCESS FOR THE PREPARATION OF 2-{4-[2-({[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]METHYL}SULFANYL)-3,5-DICYAN0-6-(PYRROLIDIN-1-YL)PYRIDIN-4-YL]PHENOXY}ETHYL-L-ALANYL-L-ALANINATE MONOHYDROCHLORIDE | May 1, 2016 | Abandoned |
Array
(
[id] => 12769822
[patent_doc_number] => 20180148442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Polycyclic Indoline and Indolenine Compounds
[patent_app_type] => utility
[patent_app_number] => 15/569186
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569186
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569186 | Polycyclic indoline and indolenine compounds | Apr 28, 2016 | Issued |
Array
(
[id] => 14145589
[patent_doc_number] => 10253153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Linker and support for solid phase synthesis of nucleic acid, and production method of nucleic acid using said support
[patent_app_type] => utility
[patent_app_number] => 15/136536
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8891
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136536 | Linker and support for solid phase synthesis of nucleic acid, and production method of nucleic acid using said support | Apr 21, 2016 | Issued |
Array
(
[id] => 11290422
[patent_doc_number] => 20160340355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'COMPOUNDS FOR TREATMENT OF METABOLIC SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/136277
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17107
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136277
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136277 | COMPOUNDS FOR TREATMENT OF METABOLIC SYNDROME | Apr 21, 2016 | Abandoned |
Array
(
[id] => 12637179
[patent_doc_number] => 20180104223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 15/567555
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/567555 | TREATMENT OF PAIN | Apr 21, 2016 | Abandoned |
Array
(
[id] => 11031471
[patent_doc_number] => 20160228427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'NOVEL PIPERIDINE COMPOUND OR SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/131372
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21146
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131372
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131372 | Piperidine compound or salt thereof | Apr 17, 2016 | Issued |
Array
(
[id] => 12680668
[patent_doc_number] => 20180118722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => NOVEL ARYL-CYANOGUANIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/566971
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566971 | NOVEL ARYL-CYANOGUANIDINE COMPOUNDS | Apr 13, 2016 | Abandoned |
Array
(
[id] => 14294363
[patent_doc_number] => 10287297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Epoxyazulene derivatives useful for treating cancer and diabetes
[patent_app_type] => utility
[patent_app_number] => 15/564353
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 48
[patent_no_of_words] => 18399
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564353
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564353 | Epoxyazulene derivatives useful for treating cancer and diabetes | Apr 12, 2016 | Issued |
Array
(
[id] => 11023603
[patent_doc_number] => 20160220558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2'
[patent_app_type] => utility
[patent_app_number] => 15/094517
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11194
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/094517 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | Apr 7, 2016 | Abandoned |
Array
(
[id] => 12750385
[patent_doc_number] => 20180141962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => AZACARBAZOLE BTK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/564349
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564349 | AZACARBAZOLE BTK INHIBITORS | Apr 3, 2016 | Abandoned |